Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia
Status:
Completed
Trial end date:
2019-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this observational study is to evaluate the prostatic arterial embolization
(PAE) with Embozene® Microspheres (Boston Scientific) in sphere sizes of 250 µm for the
treatment of symptomatic benign prostatic hyperplasia (BPH).